Acknowledgments The authors are thankful for the financial support from the Henan Provincial Science and Technology Research Project (242102311184), Natural Science Foundation of Hubei province (2023AFD224), the Open Fund of Key Laboratory of Edible Oil Quality and Safety for State Market Regulation (SYYKF202310), and China Postdoctoral Science Foundation (2021M702937)
[9] Consideraciones de seguridad importantes incluyen: Contraindicacin en pacientes con historia personal o familiar de carcinoma medular de tiroides o sndrome de neoplasia endocrina mltiple tipo 2 [1] [2] Consideraciones renales: La mayora de los agonistas GLP-1 (semaglutida, dulaglutida, liraglutida, tirzepatida) no requieren ajuste de dosis por funcin renal
The drug combination of GLP-1 RA and insulin to utilize both their merits (FBG: Fasting blood glucose
Oya M, Kitaguchi T, Pais R, Reimann F, Gribble F, Tsuboi T
NPs typically require a master's degree, clinical certification, and current licensure